Literature DB >> 7630621

Aqueous flare and retinal capillary changes in eyes with diabetic retinopathy.

N X Nguyen1, U Schönherr, M Küchle.   

Abstract

We examined 112 eyes of 112 adult-onset diabetic patients by fundus fluorescein angiography and with the laser flare cell meter (LFCM) in order to evaluate the possible correlation between retinal capillary changes and aqueous flare. Diabetic eyes were divided into the following groups: minor background diabetic retinopathy (MDR), nonproliferative diabetic retinopathy with predominant capillary occlusion (ONP), nonproliferative diabetic retinopathy with predominant capillary dilation and exudation (ENP) and proliferative diabetic retinopathy (PDR). 108 age-matched eyes of 108 normal subjects were used as control group. Flare values (photon counts/ms) of all diabetic groups (MDR 9.01 +/- 0.79, ONP 13.66 +/- 3.22, ENP 16.43 +/- 5.55, PDR 18.57 +/- 6.99) were significantly higher than in the normal control group (4.28 +/- 1.14, p < 0.0001). Significant differences were found between ONP and ENP (p = 0.008) and between ONP and PDR (p = 0.0001) but not between ENP and PDR (p = 0.4). Our results indicate that there is a correlation between aqueous flare and the type of angiographic retinal capillary changes with higher flare values in eyes with retinal capillary dilatation and exudation. Measurements with LFCM may be useful to quantify the extent and severity of capillary alterations in diabetic eyes.

Entities:  

Mesh:

Year:  1995        PMID: 7630621     DOI: 10.1159/000310601

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  9 in total

Review 1.  Laser flare photometry: a noninvasive, objective, and quantitative method to measure intraocular inflammation.

Authors:  Ilknur Tugal-Tutkun; Carl P Herbort
Journal:  Int Ophthalmol       Date:  2009-05-09       Impact factor: 2.031

2.  Use of laser flare-cell photometry to quantify intraocular inflammation in patients with Behçet uveitis.

Authors:  Ilknur Tugal-Tutkun; Kürsat Cingü; Nur Kir; Baris Yeniad; Meri Urgancioglu; Ahmet Gül
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-05-27       Impact factor: 3.117

Review 3.  Laser flare-cell photometer: principle and significance in clinical and basic ophthalmology.

Authors:  Mitsuru Sawa
Journal:  Jpn J Ophthalmol       Date:  2016-11-25       Impact factor: 2.447

4.  Corneal autofluorescence in choroidal melanoma or in choroidal naevus.

Authors:  R P Müskens; J A Van Best; J C Bleeker; J E Keunen
Journal:  Br J Ophthalmol       Date:  2001-06       Impact factor: 4.638

Review 5.  Intraocular Inflammation in Diabetic Populations.

Authors:  Wajiha J Kheir; Huda A Sheheitli; Rola N Hamam
Journal:  Curr Diab Rep       Date:  2017-08-08       Impact factor: 4.810

6.  Blood-aqueous barrier integrity in patients with Graves' ophthalmopathy (GO), before and after rehabilitative surgery.

Authors:  A Kłysik; M Kozakiewicz
Journal:  Eye (Lond)       Date:  2015-02-13       Impact factor: 3.775

7.  Damage to the blood-aqueous barrier in eyes with primary angle closure glaucoma.

Authors:  Xiangyun Kong; Xing Liu; Xiangkun Huang; Zhen Mao; Yimin Zhong; Wei Chi
Journal:  Mol Vis       Date:  2010-10-08       Impact factor: 2.367

8.  Assessment of Central Visual Function in Patients with Retinitis Pigmentosa.

Authors:  Kohta Fujiwara; Yasuhiro Ikeda; Yusuke Murakami; Takashi Tachibana; Jun Funatsu; Yoshito Koyanagi; Shunji Nakatake; Noriko Yoshida; Shintaro Nakao; Toshio Hisatomi; Shigeo Yoshida; Takeshi Yoshitomi; Tatsuro Ishibashi; Koh-Hei Sonoda
Journal:  Sci Rep       Date:  2018-05-23       Impact factor: 4.379

9.  Aqueous Flare and Progression of Visual Field Loss in Patients With Retinitis Pigmentosa.

Authors:  Kohta Fujiwara; Yasuhiro Ikeda; Yusuke Murakami; Takashi Tachibana; Jun Funatsu; Yoshito Koyanagi; Shunji Nakatake; Shotaro Shimokawa; Noriko Yoshida; Shintaro Nakao; Toshio Hisatomi; Tatsuro Ishibashi; Koh-Hei Sonoda
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-07-01       Impact factor: 4.799

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.